Lupin gains nearly 3% post US FDA nod to infection drug News News / News 6 years ago 436 Views comments Pharma major got the regulatorâs nod to market a generic version of Valeant Pharmaâs Ancobon capsules. Read more
News Invesco keen on bottom-up stock picking; like consumption, housing themes News / News - 6 years ago
News Senate confirms 3 Indian-Americans to key US government#39;s positions News / News - 6 years ago
News After a dignified decade, Hamid Ansari set to sign off as Vice-President News / News - 6 years ago
Comments